Regulators in the Central Authority for Supervision of Medicinal Products in Bavaria have charged a Hyderabad, India-based manufacturing site run by Dr. Reddy's Laboratories with non-compliance of good manufacturing practices, according to RAPS.
Based on an August inspection, the non-compliance report says the plant had one critical deficiency related to important elements of its quality system. The facility manufactures and packages non-sterile capsules and tablets, the story said, and regulators asked that they not supply product to the EU until there is a successful re-inspection.
Read the full article